Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Newron PharmaceuticalsSierra OncologyGemphire TherapeuticsHelix BiopharmaSavara
SymbolOTCMKTS:NWPHFNASDAQ:SRRANASDAQ:GEMPOTCMKTS:HBPCFNASDAQ:SVRA
Price Information
Current Price$7.50$15.48$23.77$0.97$2.45
52 Week RangeN/ABuyBuyN/ABuy
Analyst Ratings
Consensus RecommendationN/ABuyBuyN/ABuy
Consensus Price TargetN/A$1.20N/AN/A$8.60
% Upside from Price TargetN/A-92.25% downsideN/AN/A251.02% upside
Trade Information
Market Cap$133.80 million$149.69 million$353.46 million$124.05 million$100.96 million
Beta0.211.322.82-0.31.01
Average VolumeN/A67,295116,31820406,942
Sales & Book Value
Annual Revenue$4.75 millionN/AN/AN/AN/A
Price / Sales28.17N/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.63 per share$50.82 per share$0.54 per share($0.02) per share$3.08 per share
Price / Book2.07N/AN/AN/AN/A
Profitability
Net Income$-17,760,000.00$-53,330,000.00$-23,640,000.00$-5,680,000.00$-61,520,000.00
EPS($0.99)($30.00)N/AN/A($1.29)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/A-71.69%-419.70%N/A-46.13%
Return on Assets (ROA)N/A-60.87%-173.05%-539.45%-33.68%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.22%0.07%N/AN/A0.23%
Current Ratio8.29%7.69%0.67%1.24%13.07%
Quick RatioN/A7.69%0.67%1.24%13.07%
Ownership Information
Institutional Ownership PercentageN/AN/A17.53%N/A35.82%
Insider Ownership PercentageN/A67.68%22.70%7.60%6.50%
Miscellaneous
Employees2479922N/A
Shares Outstanding17.84 million9.67 million14.87 million127.89 million41.21 million
Next Earnings Date3/3/2020 (Estimated)2/27/2020 (Estimated)N/A3/16/2020 (Estimated)3/11/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel